Integrin Antibody

HPN536 is a trispecific T-cell engager targeting mesothelin on tumor cells and CD3ε on T cells, with an albumin-binding domain for extended half-life. It potently redirects and activates T cells for the lysis of mesothelin-expressing cancers, supporting research in immunotherapy and preclinical in vitro and in vivo studies.